1 - 9 of 9 Results Clear All
New data show therapies may activate lymph nodes to produce tumor-tackling T cells
News Release Research (Publication) Cancer Genomic Immunology Spitzer Lab
Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.
Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing
STAT News—The Parker Institute for Cancer Immunotherapy has expanded to include a new center at Gladstone Institutes. Center Director Alex Marson says the funding will enable Gladstone scientists to take on bold, high-risk ideas and create better cell therapies for cancer.
Institutional News Cancer Genomic Immunology Marson Lab
Researchers at the Gladstone-UCSF Institute of Genomic Immunology are learning how to harness the power of the human immune system in new ways
Gladstone Experts Cancer Genomic Immunology Carnevale Lab Doudna Lab Marson Lab Pelka Lab Roybal Lab Tang Lab Ye Lab
New Approach Analyzes How Well Different Re-Engineered T Cells Work Against Cancer
News Release Research (Publication) Cancer Genomic Immunology Roybal Lab
The new research center will accelerate cures for the world’s gravest cancers
Institutional News News Release Cancer Marson Lab
A Gene Not Previously Known to Regulate Immunity Could Turn Tired T-Cells Around
News Release Research (Publication) Cancer Genomic Immunology Carnevale Lab Marson Lab
The new study paves the way toward more effective cancer immunotherapies
News Release Cancer Genomic Immunology Marson Lab
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancer
News Release Research (Publication) Cancer Genomic Immunology
